SCHEMBL2830356

SCHEMBL2830356

CC(C)(C)c1cc2c(c(C(C)(C)C)c1)NC(=O)C2=O

nearest known ligand 0.42

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
CES1 P23141 10/20 0.42
ALDH1A1 P00352 2/20 0.42
ALDH2 P05091 1/20 0.42
ALDH3A1 P30838 1/20 0.42
TGM2 P21980 1/20 0.41
DNMT1 P26358 1/20 0.41
DAO P14920 2/20 0.37
L3MBTL1 Q9Y468 2/20 0.37
NPC1 O15118 1/20 0.37
PLA2G1B P04054 1/20 0.37
NFKB1 P19838 1/20 0.37
CASP3 P42574 1/20 0.37
RAB9A P51151 1/20 0.37
NFKB2 Q00653 1/20 0.37
RELA Q04206 1/20 0.37
SENP8 Q96LD8 1/20 0.37
SENP7 Q9BQF6 1/20 0.37
SENP6 Q9GZR1 1/20 0.37
ATG4B Q9Y4P1 1/20 0.37
GABBR2 O75899 1/20 0.35

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL18702831 0.84 CES1 (0.61) CES1ALDH1A1ALDH2ALDH3A1TGM2
SCHEMBL14995633 0.81 ALDH1A1 (0.49) CES1ALDH1A1ALDH2ALDH3A1TGM2
SCHEMBL695322 0.76 MEN1 (0.50) CES1ALDH1A1ALDH2ALDH3A1TGM2
SCHEMBL4555257 0.75 CES1 (0.57) CES1ALDH1A1ALDH2ALDH3A1TGM2
SCHEMBL712833 0.73 CES1 (0.69) CES1ALDH1A1ALDH2ALDH3A1DAO
SCHEMBL29976912 0.71 ALDH1A1 (0.42) ALDH1A1L3MBTL1NPC1PLA2G1BNFKB1
SCHEMBL1247409 0.69 TGM2 (0.55) CES1ALDH1A1TGM2L3MBTL1NPC1
SCHEMBL30541907 0.69 TGM2 (0.55) CES1ALDH1A1TGM2L3MBTL1NPC1
SCHEMBL1171494 0.69 GABRA1 (0.43) ALDH1A1L3MBTL1NPC1PLA2G1BNFKB1
SCHEMBL4555733 0.68 CES1 (0.59) CES1ALDH1A1ALDH2ALDH3A1TGM2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 7 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1915357-B1 2-HYDROXY-PROPIONIC ACID DERIVATIVES AND 3-HYDROXY-BENZOFURAN-2-ONE DERIVATIVES WITH AFFINITY FOR THE GABA-B-RECEPTOR HOFFMANN LA ROCHE (CH) 2010-09-08 EP disclosed
US-7504428-B2 2-phenyl-3,3,3-trifluoro-2-hydroxy-propionic acid derivatives HOFFMAN-LA ROCHE INC. (US) 2009-03-17 US disclosed
US-20080234356-A1 2-PHENYL-3,3,3-TRIFLUORO-2-HYDROXY-PROPIONIC ACID DERIVATIVES MALHERBE PARICHEHR 2008-09-25 US disclosed
US-7396853-B2 2-phenyl-3,3,3-trifluoro-2-hydroxy-propionic acid derivatives HOFFMANN-LA ROCHE INC. (US) 2008-07-08 US disclosed
EP-1915357-A1 2-HYDROXY-PROPIONIC ACID DERIVATIVES AND 3-HYDROXY-BENZOFURAN-2-ONE DERIVATIVES WITH AFFINITY FOR THE GABA-B-RECEPTOR F. Hoffmann-Roche AG (CH) 2008-04-30 EP disclosed
WO-2007014843-A1 2-HYDROXY-PROPIONIC ACID DERIVATIVES AND 3-HYDROXY-BENZOFURAN-2-ONE DERIVATIVES WITH AFFINITY FOR THE GABA-B-RECEPTOR F. HOFFMANN-LA ROCHE AG (CH) 2007-02-08 WO disclosed
US-20070027204-A1 2-phenyl-3,3,3-trifluoro-2-hydroxy-propionic acid derivatives F. HOFFMANN-LA ROCHE AG, A SWISS COMPANY (CH) 2007-02-01 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20070027204-A1 2-phenyl-3,3,3-trifluoro-2-hydroxy-propionic acid derivatives GABRA3, GABRA2, GABRA1 CES1 778/4885ALDH1A1 225/4885ALDH2 216/4885
US-20080234356-A1 2-PHENYL-3,3,3-TRIFLUORO-2-HYDROXY-PROPIONIC ACID DERIVATIVES GABBR1, GABRA2, GABRA3 CES1 1615/4885ALDH1A1 270/4885ALDH2 337/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.